It is therefore likely that the Matrigel but not the CIM-plate 16 microporous membrane itself or its collagen coating provides integrin ligands that are crucial for TGF-β-driven cell motility in primary breast cancer cells, a hypothesis that is currently being tested in our laboratory. This evidence concerns the gene TGFB1 and breast carcinoma.